Shanghai Juding Biotechnology Co., Ltd. was established in September 2020. It is a high-tech biotech company integrating R&D and sales, serving clients in the biopharmaceutical industry and research institutions. The company focuses on two core areas — cell culture and molecular biology — and is committed to providing reliable and high-performance reagents and cellular resources for life science research and biomedical development.

In the field of cell culture, the company offers products under its KEL Biotech brand, including fetal bovine serum (FBS), culture media, trypsin, penicillin-streptomycin (dual antibiotics), and serum-free cryopreservation media, comprehensively covering key steps in cell culture. In molecular biology, the company provides enzyme reagents for PCR and qPCR applications to support gene detection and analysis. In addition, the company has established a comprehensive cell resource bank, comprising primary cells and various cell lines, providing essential support for scientific research and product development.

Juding Biotech adheres to a technology-driven and customer-oriented approach, continuously expanding its product portfolio and enhancing service quality, with the goal of becoming a trusted partner in the field of biological reagents and cellular resources.